In malignant melanoma as in many other malignancies the process of tumorige
nesis and progression appears to result from the accumulation of multiple g
enetic lesions. Linkage analyses in melanoma families gave evidence for 2 s
till unknown predisposing genes, located in the chromosomal bands 1p36 and
9p21. Present data indicate that the p16 (CDKN2) tumor suppressor gene may
be involved in early stages of melanoma progression. Additionally, malfunct
ion of the p53 gene as well as inactivation of genes not yet identified on
chromosome arms 6q, 10p and 10q seem to be involved in early stages of mela
noma pathogenesis. However, these genetic alterations could not be associat
ed with clinically defined stages of melanoma progression such as radial (R
GP) or vertical growth phase (VGP). Paralleling findings in other malignanc
ies loss of genetic material of chromosome bands 11q23 and 1p36 as well as
gain of chromosome bands 7q33-qter have been detected in late stage tumors
and are likely to be associated with the capability to metastasize. Intense
efforts in the field of melanoma genetics promise the identification and c
haracterization of the respective genes in the near future.